0000000000073914

AUTHOR

Nina Pfannkuchen

showing 3 related works from this author

In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases

2018

Background Conjugates of bisphosphonates with macrocyclic chelators possess high potential in bone targeted radionuclide imaging and therapy. DOTAZOL, zoledronic acid conjugated to DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), demonstrated promising results in vivo in small animals as well as in first patient applications using 68Ga for diagnosis via PET and the lowenergy β-emitter 177Lu for therapy of painful bone metastases. In consideration of the fact that targeted α-therapy probably offers various advantages over the use of β--emitters, the 225Ac-labelled derivative [225Ac]Ac-DOTAZOL was synthesized and evaluated in vivo. Here, we report on radiolabelling and biodist…

PharmacologyKidneymedicine.medical_specialtyBiodistributionbusiness.industryPharmacology030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicine.anatomical_structureZoledronic acidchemistryIn vivo030220 oncology & carcinogenesisToxicityDOTAMedicineRadiology Nuclear Medicine and imagingHistopathologybusinessEx vivomedicine.drugCurrent Radiopharmaceuticals
researchProduct

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases.

2017

Bone metastases, often a consequence of breast, prostate, and lung carcinomas, are characterized by an increased bone turnover, which can be visualized by positron emission tomography (PET), as well as single-photon emission computed tomography (SPECT). Bisphosphonate complexes of 99mTc are predominantly used as SPECT tracers. In contrast to SPECT, PET offers a higher spatial resolution and, owing to the 68Ge/68Ga generator, an analog to the established 99mTc generator exists. Complexation of Ga(III) requires the use of chelators. Therefore, DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), NOTA (1,4,7-triazacyclododecane-1,4,7-triacetic acid), and their derivatives, are ofte…

diagnosismedicine.medical_treatmentPharmaceutical ScienceReview030218 nuclear medicine & medical imagingBone remodeling03 medical and health scienceschemistry.chemical_compound0302 clinical medicinebone metastasesDrug DiscoverymedicineDOTAbisphosphonatestherapymedicine.diagnostic_testbusiness.industryBisphosphonate177Lu68GachemistryPositron emission tomography030220 oncology & carcinogenesisMolecular MedicineNuclear medicinebusinessEmission computed tomographyPharmaceuticals (Basel, Switzerland)
researchProduct

68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika

2015

Der erhohte Metabolismus der Knochenmatrix kann zum einen mit der SPECT- und zum anderen mit der PET-Technik visualisiert werden. Als SPECT-Nuklid wird uberwiegend 99 mTc in Form von [99mTc]Bisphosphonat-Komplexen verwendet. Die PET bietet im Gegensatz zur SPECT eine hohere lokale und temporale Auflosung. Mit dem 68Ge/68Ga-Generatorsystem existiert ein mittlerweile bewahrtes PET-Pendant zum etablierten 99mTc-Generator. Neuartige Bisphosphonate (BP) in Kombination mit makrozyklischen Chelatoren sind derzeit weltweit Gegenstand der Forschung. Zur Komplexierung von Ga(III) werden haufig DOTA und NOTA sowie deren Derivate verwendet. Speziell im Fall von DOTA-Derivaten bieten DOTA-BP die Moglich…

GynecologyPhysicsmedicine.medical_specialtyOncologymedicineDer Nuklearmediziner
researchProduct